Listed

Citius Oncology, Inc.

CTORNasdaqCIK 1851484HealthcareFiscal year ends Sep 30

Reports and events: 93 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Citius Oncology, Inc., Reports and events
FiledFormWhat it isAccession number
2025-01-0608:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-25-000953
2024-12-2717:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001213900-24-113159
2024-12-2717:00 ET10-KAnnual reportPeriod 2024-09-300001213900-24-113150
2024-11-1208:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-096269
2024-09-1308:30 ET8-K1.01 Entry into a material agreement0001213900-24-078287
2024-09-0516:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-24-076111
2024-08-2616:15 ET8-K/A2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001213900-24-072598
2024-08-1617:25 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits0001213900-24-070335
2024-08-1616:34 ETSC 13DOwnership report, active investor0001213900-24-070284
2024-08-1512:53 ETSC 13D/AOwnership report, active investor, amended0001493152-24-032563
2024-08-0916:22 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-030991
2024-08-0520:45 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-030145
2024-07-1915:39 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-24-028500
2024-06-1813:35 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-24-024236
2024-06-0617:28 ET8-K8.01 Other events0001493152-24-022977
2024-05-2115:07 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-24-020866
2024-05-2017:27 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-020783
2024-04-2916:45 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-24-017024
2024-04-1617:00 ET10-KAnnual reportPeriod 2023-12-310001493152-24-014850
2024-01-1816:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-002896
2024-01-1016:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-001958
2024-01-0816:46 ETDEF 14AProxy statementPeriod 2024-01-080001493152-24-001720
2023-11-2017:25 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-042170
2023-10-2407:41 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-038045
2023-10-1817:20 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-037635
2023-08-1614:44 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-029131
2023-07-1816:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-024835
2023-05-1516:19 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-017394
2023-04-1716:18 ET10-KAnnual reportPeriod 2022-12-310001493152-23-012545
2022-12-0617:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-034614
2022-11-2816:55 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-033847
2022-10-2816:59 ETSC 13DOwnership report, active investor0001493152-22-029872
2022-10-2417:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-029450
2022-10-1916:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-028873
2022-09-1217:22 ETS-1/ARegistration statement, amended0001493152-22-025658
2022-07-2915:25 ETS-1/ARegistration statement, amended0001493152-22-020683
2022-05-2421:52 ETS-1/ARegistration statement, amended0001493152-22-014854
2022-05-1117:21 ETS-1/ARegistration statement, amended0001493152-22-012880
2022-04-0116:29 ETS-1/ARegistration statement, amended0001493152-22-008828
2022-03-0817:10 ETS-1/ARegistration statement, amended0001493152-22-006313
2021-08-2017:28 ETS-1/ARegistration statement, amended0001493152-21-020860
2021-06-3017:45 ETS-1/ARegistration statement, amended0001493152-21-015601
2021-05-1918:37 ETS-1Registration statement0001493152-21-012185

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:33 ET. Listed shows no prices and gives no investment advice.